SITAFLOXACIN-BASED THIRD-LINE ERADICATION OF HELICOBACTER PYLORI

(1) Keio University, Dept. of Internal Medicine, Tokyo, Japan

(2) Division of Gastroenterology and Hepatology, Department of Internal Medicine, KEIO UNIVERSI

(3) Gastroenterology, NationalTokyo Medical Center, Tokyo, Japan

(4) Chemotherapy, MitsubishiChemical Medience, Tokyo, Japan



This item was part of the New insights in H. pylori infection session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A47

You may be interested in:

Improvement in the quality of life related to reflux symptoms after Helicobacter pylori eradication therapy
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012
The Gerd-Q is a useful tool for evaluating the patients’ satisfaction and identifying the patients with “unmet medical needs”
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2010